Russia register’s first Covid-19 vaccine, here is how people reacted:
Yesterday we all got a little sigh of relief, as President Vladimir Putin on Tuesday announced that Russia was the first country to grant regulatory approval to a Covid-19 vaccine for civilian use. As thousands of medical experts around the world are working hard to develop a vaccine, Russia has finally done it.
Putin said the Covid-19 vaccine, dubbed Sputnik V, “works quite effectively” and “forms a stable immunity” against Covid-19. He also disclosed that one of his two daughters had received a shot of the vaccine and was feeling well. Though, experts have expressed doubt regarding its safety and effectiveness since it is being approved for civilian use even before clinical trials are completed.
Describing the vaccine as a ‘very important step for the world’, he thanked the people who have worked on developing the vaccine.
Right after the announcement, #RussianVaccine has been trending on Twitter, with netizens tweeting to express their concerns. However, many have come up with memes and jokes.
Check out the memes below:
— Shashwat ️ (@_Shakti_maan) August 11, 2020
Putin to corona : pic.twitter.com/yQCUBVopUs
— Gujrati Chhokro (@pubgkadeewana) August 11, 2020
— Danish Sait (@DanishSait) August 11, 2020
Russia announces worlds first #CoronavirusVaccine
— Bhoomika maheshwari (@__Sankii__) August 11, 2020
Russia developed world’s first Covid-19 Vaccine.
— ℛℴ . (@Rohitkumarr_) August 11, 2020
Russia announces world’s first Covid-19 vaccine…
— Khuc__ (@Khuc36843560) August 11, 2020
— Kishan (@KishanJotaniya) August 11, 2020
Putin to other world leaders right now :
— Tayyab Shahid (@Tayyab_shahid_) August 12, 2020
— Pragya Shukla (@ocean_waves_07) August 12, 2020
The vaccine will now move to its final stage of the clinical trials. The Phase 3 trial involves testing on thousands of participants infected with the virus to observe the vaccine’s effectiveness before it gets regulatory approval and can be made available for mass use. Russia’s vaccine has been developed after less than two months of human testing.